BioSpace News Archive

Cognate BioServices announced today it has completed a management buyout (“MBO”) and raised capital from a group of global investment firms.

Research funded by The ALS Association’s Lawrence and Isabel Barnett Drug Development Program recently uncovered a new way to slow muscle paralysis in mice with ALS, findings that could point to new approaches to therapy for people with ALS.

These expanded indications mean that patients who have an obstructive median lobe and those as young as 45 are now eligible to receive treatment with the UroLift System for their BPH symptoms.

[20-February-2018] LOS ANGELES, February 20, 2018 /PRNewswire/ -- Cannabis Strategic Ventures, Inc. (OTC Pink: NUGS) today announces it has signed an agreement to acquire Pure Applied Sciences and its brand PureOrganix, a line of organic and pure cannabis oils and related accessories. The acquisition, which has been finalized, will include all of Pure Applied Sciences in

Nativis, Inc., a clinical-stage therapeutic device company developing non-sterile, non-invasive, non-thermal treatments for cancers and other serious diseases, announced it has received notice from the Food & Drug Administration (FDA) that the Nativis Voyager Pediatric system has been granted a Humanitarian Use Designation (HUD).

Attune Medical (formerly Advanced Cooling Therapy) has promoted COO Keith Warner to Chief Executive Officer.

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it has licensed IONIS-AZ5-2.5 Rx (AZD2373) to the global, science-led biopharmaceutical company AstraZeneca (NYSE: AZN).

The antiretroviral (ARV) will be immediately available in developing countries as a first-line regimen for people being treated for HIV/AIDS.

Study Expected to Expand to Five Hospitals and Evaluate Accuracy of the VIVO System.